These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38150401)

  • 1. Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease.
    Negatu DA; Shin SJ; Kim SY; Jhun BW; Dartois V; Dick T
    J Infect Dis; 2024 Aug; 230(2):e241-e246. PubMed ID: 38150401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
    Negatu DA; Zimmerman MD; Dartois V; Dick T
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0079022. PubMed ID: 36047786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ertapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model.
    Deshpande D; Srivastava S; Gumbo T
    Int J Antimicrob Agents; 2024 Sep; 64(3):107204. PubMed ID: 38754528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in drug susceptibility distribution and clinical characteristics between
    Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Yamatani I; Aono A; Fujiwara K; Asami T; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Komiya K; Mitarai S
    Microbiol Spectr; 2024 Jul; 12(7):e0008424. PubMed ID: 38842354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Maintenance and Redevelopment of Nontuberculous Mycobacteria Pulmonary Disease after Treatment of Mycobacterium avium Complex Pulmonary Disease.
    Zo S; Kim H; Kwon OJ; Jhun BW
    Microbiol Spectr; 2022 Aug; 10(4):e0108822. PubMed ID: 35950873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against
    Dousa KM; Shin E; Kurz SG; Plummer M; Nantongo M; Bethel CR; Taracila MA; Nguyen DC; Kreiswith BN; Daley CL; Remy KE; Holland SM; Bonomo RA
    mBio; 2024 Jun; 15(6):e0060924. PubMed ID: 38742824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.
    Daley CL; Winthrop KL
    J Infect Dis; 2020 Aug; 222(Suppl 4):S199-S211. PubMed ID: 32814943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend.
    Griffith DE; Aksamit TR
    Chest; 2021 Apr; 159(4):1372-1381. PubMed ID: 33080299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
    J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pairwise approach to revitalize β-lactams for the treatment of TB.
    Negatu DA; Aragaw WW; Dartois V; Dick T
    Antimicrob Agents Chemother; 2024 May; ():e0003424. PubMed ID: 38690896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
    Hosono Y; Kitada S; Yano Y; Mori M; Miki K; Miki M; Yoshimura K; Kagawa H; Oshitani Y; Yokota S
    J Infect Chemother; 2018 May; 24(5):353-357. PubMed ID: 29361415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bigger problems from smaller colonies: emergence of antibiotic-tolerant small colony variants of Mycobacterium avium complex in MAC-pulmonary disease patients.
    Park HE; Kim KM; Trinh MP; Yoo JW; Shin SJ; Shin MK
    Ann Clin Microbiol Antimicrob; 2024 Mar; 23(1):25. PubMed ID: 38500139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients.
    Deshpande D; Magombedze G; Boorgula GD; Chapagain M; Srivastava S; Gumbo T
    J Infect Dis; 2024 Aug; 230(2):e230-e240. PubMed ID: 38036299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
    Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
    Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.